The Molecular Basis of Heat-Stable Enterotoxin for Vaccine Development and Cancer Cell Detection

Heat-stable enterotoxin (ST<sub>a</sub>) produced by Enterotoxigenic <i>E. coli</i> is responsible for causing acute diarrhea in infants in developing countries. However, the chemical synthesis of ST<sub>a</sub> peptides with the native conformation and the correc...

Full description

Bibliographic Details
Main Authors: Masaya Goto, Shinya Yoshino, Kyona Hiroshima, Toru Kawakami, Kaeko Murota, Shigeru Shimamoto, Yuji Hidaka
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/3/1128
Description
Summary:Heat-stable enterotoxin (ST<sub>a</sub>) produced by Enterotoxigenic <i>E. coli</i> is responsible for causing acute diarrhea in infants in developing countries. However, the chemical synthesis of ST<sub>a</sub> peptides with the native conformation and the correct intra-molecular disulfide bonds is a major hurdle for vaccine development. To address this issue, we herein report on the design and preparation of ST<sub>a</sub> analogs and a convenient chemical method for obtaining ST<sub>a</sub> molecules with the correct conformation. To develop an ST<sub>a</sub> vaccine, we focused on a structure in a type II β-turn in the ST<sub>a</sub> molecule and introduced a D-Lys residue as a conjugation site for carrier proteins. In addition, the -Glu-Leu- sequence in the ST<sub>a</sub> molecule was replaced with a -Asp-Val- sequence to decrease the toxic activity of the peptide to make it more amenable for use in vaccinations. To solve several issues associated with the synthesis of ST<sub>a</sub>, such as the formation of non-native disulfide isomers, the native disulfide pairings were regioselectively formed in a stepwise manner. A native form or topological isomer of the designed ST<sub>a</sub> peptide, which possesses a right-handed or a left-handed spiral structure, respectively, were synthesized in high synthetic yields. The conformation of the synthetic ST<sub>a</sub> peptide was also confirmed by CD and NMR spectroscopy. To further utilize the designed ST<sub>a</sub> peptide, it was labeled with fluorescein for fluorescent detection, since recent studies have also focused on the use of ST<sub>a</sub> for detecting cancer cells, such as Caco-2 and T84. The labeled ST<sub>a</sub> peptide was able to specifically and efficiently detect 293T cells expressing the recombinant ST<sub>a</sub> receptor (GC-C) protein and Caco-2 cells. The findings reported here provide an outline of the molecular basis for using ST<sub>a</sub> for vaccine development and in the detection of cancer cells.
ISSN:1420-3049